Neurological Soft Signs in Type I Bipolar Disorder and Bipolar Spectrum Patients and Their Unaffected First-Degree Relatives: A Cross-Sectional Study
- PMID: 39807480
- PMCID: PMC11725529
- DOI: 10.1002/hsr2.70341
Neurological Soft Signs in Type I Bipolar Disorder and Bipolar Spectrum Patients and Their Unaffected First-Degree Relatives: A Cross-Sectional Study
Abstract
Background and aims: This study aimed to compare neurological soft signs (NSSs) in type 1 bipolar disorder (BD), bipolar spectrum (BS) patients, and their unaffected first-degree relatives.
Methods: This descriptive cross-sectional study involved participants referred to the Psychiatric Department of Imam Hossein Hospital. Five groups (n = 25): patients with type 1 BD, patients with BS, unaffected first-degree relatives of the two groups, and a control group were evaluated using the Neurological Evaluation Scale (NES).
Results: The analysis revealed that patients with bipolar I disorder had the highest NES scores, with significant group differences (F(4.120) = 10.36, p < 0.001). The Bonferroni correction identified bipolar I patients as the primary source of this difference, while other groups did not significantly differ. ANCOVA showed that age (F(1.123) = 3.92, p = 0.052) and gender (F(1.123) = 0.1, p = 0.75) had no significant influence on NES scores. However, all four NES subsets significantly contributed to the overall score, except for the sensory subset. Differences were significant between bipolar I patients and most other groups, except the BS group, which showed no significant differences from the rest. No correlation was found with age, gender, or age of disease onset.
Conclusion: The higher NSS severity in type I BD compared to BS and control groups highlights its potential link to the genetic and neurodevelopmental differences in BD type I. Further research is recommended.
Keywords: bipolar and related disorders; bipolar disorder; neurologic manifestations.
© 2025 The Author(s). Health Science Reports published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Michael F. G., “Schizophrenia,” in Sadock Comprehensive Textbook of Psychiatry (10th ed.), eds. Sadock B. and Kaplan S. V. (Philadelphia: Lippincott Williams & Wilkins, 2012), 1117–1147.
-
- Hosseini S. H., Abedini M., Khalilian A., and Farghani F., “Relationship of Neurologic Signs With Schizophrenia,” Journal of Babol University of Medical Sciences 6, no. 2 (2004): 61–67.
-
- Bombin I., “Significance and Meaning of Neurological Signs in Schizophrenia: Two Decades Later,” Schizophrenia Bulletin 31, no. 4 (January 2005): 962–977. - PubMed
-
- Crump C., Sundquist K., Winkleby M. A., and Sundquist J., “Comorbidities and Mortality in Bipolar Disorder: A Swedish National Cohort Study,” JAMA Psychiatry 70, no. 9 (September 2013): 931–939. - PubMed
-
- Fagiolini A., Forgione R., Maccari M., et al., “Prevalence, Chronicity, Burden and Borders of Bipolar Disorder,” Journal of Affective Disorders 148, no. 2–3 (June 2013): 161–169. - PubMed
LinkOut - more resources
Full Text Sources
